JP2003183118A - Gel composition and emulsified composition - Google Patents
Gel composition and emulsified compositionInfo
- Publication number
- JP2003183118A JP2003183118A JP2001384408A JP2001384408A JP2003183118A JP 2003183118 A JP2003183118 A JP 2003183118A JP 2001384408 A JP2001384408 A JP 2001384408A JP 2001384408 A JP2001384408 A JP 2001384408A JP 2003183118 A JP2003183118 A JP 2003183118A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gel composition
- general formula
- gel
- emulsified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000001413 amino acids Chemical class 0.000 claims abstract description 5
- 239000001257 hydrogen Substances 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 12
- 239000004395 L-leucine Substances 0.000 claims description 6
- 235000019454 L-leucine Nutrition 0.000 claims description 6
- 229960003136 leucine Drugs 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 229930182844 L-isoleucine Natural products 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 230000007794 irritation Effects 0.000 abstract description 11
- 230000001804 emulsifying effect Effects 0.000 abstract description 8
- 239000000499 gel Substances 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 239000000839 emulsion Substances 0.000 description 12
- -1 alkali metal salt Chemical class 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 102100033029 Carbonic anhydrase-related protein 11 Human genes 0.000 description 2
- 101000867841 Homo sapiens Carbonic anhydrase-related protein 11 Proteins 0.000 description 2
- 101001075218 Homo sapiens Gastrokine-1 Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、一般式1に示され
る化合物および/またはその塩を含有することを特徴と
するゲル組成物および乳化組成物に関するものである。
より詳しくは、一般式1に示される化合物および/また
はその塩を含有することにより、油の乳化能が高く、経
時安定性に優れており、更には皮膚に対する刺激が低く
安全性の高いゲル組成物および乳化組成物に関する。TECHNICAL FIELD The present invention relates to a gel composition and an emulsified composition containing the compound represented by the general formula 1 and / or a salt thereof.
More specifically, by containing the compound represented by the general formula 1 and / or a salt thereof, a gel composition having high emulsifying ability of oil, excellent stability over time, and low irritation to skin and high safety And an emulsified composition.
【0002】[0002]
【従来の技術】近年、人的な安全性の面で天然またはそ
れ由来の界面活性物質を乳化剤として使用する研究がな
されてきた。その様な中で、Bacillus sub
tilis等に代表される微生物により発酵する過程で
分泌生産される一般式1に示す界面活性物質も安全性の
高い天然の乳化剤として期待され、様々な乳化方法の研
究がなされてきた。2. Description of the Related Art In recent years, studies have been made on the use of natural or derived surface-active substances as emulsifiers in terms of human safety. In such a situation, Bacillus sub
The surface-active substance represented by the general formula 1 secreted and produced in the process of fermentation by a microorganism represented by tilis and the like is also expected as a highly safe natural emulsifier, and various emulsification methods have been studied.
【0003】またヒトに対し外用する化粧用の組成物に
関しては、経時安定性に優れており、更には皮膚に対す
る刺激が低く安全性の高い界面活性物質を利用したゲル
組成物および乳化組成物が求められてきた。Further, regarding cosmetic compositions for external application to humans, gel compositions and emulsion compositions using surface-active substances which are excellent in stability over time, have low irritation to the skin, and are highly safe. I have been asked.
【0004】[0004]
【発明が解決しようとする課題】この様な状況の中で、
化粧品等の皮膚外用剤に求められる機能は天然物由来の
界面活性剤、いわゆるバイオサーファクタントの界面活
性を利用した系で、そのゲル組成物および乳化組成物を
得ること、さらには、そのゲル組成物に水を加えること
により物理的に弱い攪拌力で効率よく経時的に安定な微
細な乳化粒子を形成させること、また、皮膚に対する刺
激性が低いことである。[Problems to be Solved by the Invention] In such a situation,
The function required for an external preparation for skin such as cosmetics is a system utilizing a surfactant derived from a natural product, that is, a so-called biosurfactant, to obtain a gel composition and an emulsion composition, and further, the gel composition. That is, by adding water to the emulsion, it is possible to efficiently form fine emulsion particles that are stable over time with a physically weak stirring force, and to have low irritation to the skin.
【0005】[0005]
【課題を解決するための手段】本発明者等は、かかる実
情に鑑み鋭意検討した結果、一般式1に示される化合物
および/またはその塩を含有することにより、自己組織
体形成能が高く、経時安定性に優れており、更には油の
乳化能が高く、皮膚に対する刺激が低く安全性の高い、
ゲル組成物および乳化組成物の発明を完成するに至っ
た。Means for Solving the Problems The inventors of the present invention have made extensive studies in view of such circumstances, and as a result, by containing the compound represented by the general formula 1 and / or a salt thereof, the self-organizing ability is high, Excellent stability over time, high oil emulsifying ability, low irritation to the skin and high safety,
The invention of a gel composition and an emulsion composition was completed.
【0006】すなわち、本発明のゲル組成物および乳化
組成物は、一般式1に示される化合物および/またはそ
の塩を含有するものであり、自己組織体形成能が高く、
経時安定性に優れており、更には油の乳化能が高く、皮
膚に対する刺激が低く安全性の高い組成物である。That is, the gel composition and the emulsified composition of the present invention contain the compound represented by the general formula 1 and / or a salt thereof and have high self-organizing ability.
The composition is excellent in stability over time, has a high oil emulsifying ability, has low irritation to the skin, and is highly safe.
【0007】以下、本発明の構成について詳述する。The structure of the present invention will be described in detail below.
【0008】本発明で用いられる一般式1の物質はBa
cillus subtilis等に代表される微生物
により発酵する過程で分泌生産される、いわゆるバイオ
サーファクタントと称されるものである。The substance of the general formula 1 used in the present invention is Ba
It is a so-called biosurfactant, which is secreted and produced in the process of fermentation by a microorganism represented by Cillus subtilis.
【0009】具体的には、R1はアミノ酸であり多くは
L−ロイシン、L−イソロイシン、L−バリンから選ば
れる。R2は炭素鎖C8〜C22のアルキルであり、直
鎖状、分岐状、環状、さらには飽和、不飽和いずれでも
よい。R3は水素または、塩も使用可能でありナトリウ
ム塩、カリウム塩等のアルカリ金属塩が用いられる。さ
らには、それらの混合系でも良い。Specifically, R 1 is an amino acid, and most of them are selected from L-leucine, L-isoleucine and L-valine. R 2 is alkyl having a carbon chain of C 8 to C 22 , which may be linear, branched, cyclic, and saturated or unsaturated. As R 3 , hydrogen or a salt can be used, and an alkali metal salt such as sodium salt or potassium salt is used. Further, a mixed system thereof may be used.
【0010】本発明で用いられる一般式1に示される化
合物は、好ましくは、R1がL−ロイシン、R2が一般
式2、R3がナトリウムである。さらに含有量は、特に
限定されるものではないが0.1〜10重量%とするこ
とが好ましく、0.1重量%未満ではゲル形成能、乳化
能に劣り安定なゲル組成物および乳化組成物が得られな
い場合があり、10重量%を超えて含有することは可能
であるがゲル組成物および乳化組成物として経済的でな
い。In the compound represented by the general formula 1 used in the present invention, R 1 is L-leucine, R 2 is the general formula 2, and R 3 is sodium. Further, the content is not particularly limited, but is preferably 0.1 to 10% by weight, and if it is less than 0.1% by weight, the gel composition and the emulsion composition are inferior in gel forming ability and emulsifying ability and are stable. May not be obtained, and it is possible to contain more than 10% by weight, but it is not economical as a gel composition and an emulsion composition.
【0011】本発明の組成物は上記必須成分の他に通常
の皮膚外用剤に用いられる化粧料、医薬部外品、医薬品
等の各種成分、さらに食品に用いられる成分を配合する
ことができる。例えば油性成分、脂質、保湿剤、増粘
剤、薬効成分、殺菌・防腐剤、顔料、粉体、pH調整
剤、紫外線吸収剤、抗酸化剤、可塑剤、香料、アミノ
酸、甘味料、着色料等を適宜配合することができる。さ
らにゲル形成能や乳化能を補助する役割で他の界面活性
剤も配合することができる。In addition to the above-mentioned essential components, the composition of the present invention may contain various components such as cosmetics, quasi drugs, pharmaceuticals and the like which are commonly used in external preparations for skin, and components which are used in foods. For example, oily ingredients, lipids, humectants, thickeners, medicinal ingredients, bactericidal / preservatives, pigments, powders, pH adjusters, UV absorbers, antioxidants, plasticizers, fragrances, amino acids, sweeteners, colorants. Etc. can be blended appropriately. Further, other surfactants can be blended in the role of assisting gel forming ability and emulsifying ability.
【0012】具体的には油性成分としては、例えば流動
パラフィン、ワセリン、マイクロクリスタリンワック
ス、スクワラン、ホホバ油、ミツロウ、カルナウバロ
ウ、ラノリン、オリーブ油、ヤシ油、高級アルコール、
脂肪酸、高級アルコールと脂肪酸のエステル、シリコー
ン油等が挙げられる。保湿剤としては、例えばグリセリ
ン、ソルビトール、キシリトール、マルチトール、プロ
ピレングリコール、ポリエチレングリコール、1,3−
ブチレングリコールなどが挙げられる。増粘剤として
は、例えばカルボキシビニルポリマー、キサンタンガ
ム、メチルセルロース、ポリビニルピロリドン、ゼラチ
ン、ベントナイト等の粘土鉱物等が挙げられる。薬効成
分としては、例えば各種ビタミンおよびその誘導体、ア
ラントイン、グリチルリチン酸およびその誘導体、各種
動植物抽出物等が挙げられる。さらに乳化剤としては、
例えばポリオキシエチレンアルキルエーテル、ポリオキ
シエチレン脂肪酸エステル、ポリオキシエチレンソルビ
タン脂肪酸エステル、ソルビタン脂肪酸エステル、グリ
セリン脂肪酸エステル、ポリグリセリン脂肪酸エステ
ル、ポリオキシエチレン硬化ヒマシ油等の非イオン界面
活性剤、ステアロイル乳酸ナトリウム等のアニオン界面
活性剤、大豆リン脂質等の両性界面活性剤、塩化アルキ
ルトリメチルアンモニウム等のカチオン界面活性剤が挙
げられる。Specific examples of the oily component include liquid paraffin, petrolatum, microcrystalline wax, squalane, jojoba oil, beeswax, carnauba wax, lanolin, olive oil, coconut oil, and higher alcohols.
Examples thereof include fatty acids, esters of higher alcohols and fatty acids, silicone oils and the like. Examples of moisturizers include glycerin, sorbitol, xylitol, maltitol, propylene glycol, polyethylene glycol, 1,3-
Butylene glycol and the like can be mentioned. Examples of the thickener include carboxyvinyl polymers, xanthan gum, methylcellulose, polyvinylpyrrolidone, gelatin, clay minerals such as bentonite, and the like. Examples of the medicinal component include various vitamins and their derivatives, allantoin, glycyrrhizic acid and its derivatives, various animal and plant extracts, and the like. Furthermore, as an emulsifier,
For example, polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, nonionic surfactant such as polyoxyethylene hydrogenated castor oil, sodium stearoyl lactylate And the like, amphoteric surfactants such as soybean phospholipids, and cationic surfactants such as alkyltrimethylammonium chloride.
【0013】本発明のゲル組成物および乳化組成物は公
知の方法により製造することができ、化粧料、医薬部外
品、外用医薬品、食品等の分野を問わず利用できるもの
であり、その剤型は目的に応じて任意に選択でき、クリ
ーム、乳液、ローション、ゲル、軟膏、パック、スティ
ック等の形態とすることができる。The gel composition and the emulsified composition of the present invention can be produced by a known method and can be used regardless of the fields of cosmetics, quasi drugs, external medicines, foods, etc. The mold can be arbitrarily selected according to the purpose, and can be in the form of cream, emulsion, lotion, gel, ointment, pack, stick or the like.
【0014】[0014]
【発明の効果】本発明のゲル組成物および乳化組成物
は、一般式1に示される化合物および/またはその塩を
含有するものであり、従来より一般に用いられている天
然またはそれ由来の界面活性物質に比べ、油の乳化能が
高く、経時安定性に優れており、更には皮膚に対する刺
激が低く安全性に優れたものである。INDUSTRIAL APPLICABILITY The gel composition and emulsion composition of the present invention contain the compound represented by the general formula 1 and / or a salt thereof, and are naturally used or conventionally derived surface active agents. Compared to the substance, the emulsifying ability of oil is high, the stability over time is excellent, the irritation to the skin is low, and the safety is excellent.
【0015】これらの効果を実証するために実施例1〜
9および比較例1〜8を調製し評価した。In order to demonstrate these effects, Examples 1 to 1
9 and Comparative Examples 1-8 were prepared and evaluated.
【0016】実施例に先立ち、本発明で用いたゲル化方
法、乳化方法、経時安定性の評価、皮膚への刺激性の評
価方法を説明する。Prior to the examples, the gelation method, emulsification method, evaluation of stability over time, and evaluation method of skin irritation used in the present invention will be described.
【0017】(ゲル化方法)以下の処方にて、界面活性
物質とグリセリン(A部)を常温にて充分攪拌した後、
60℃に加温、同じく60℃に加温した油相(B部)を
A部に攪拌しながら徐々に加える。その後室温まで冷却
してゲル組成物を得た。(Gelification method) After the surface-active substance and glycerin (part A) were sufficiently stirred at room temperature according to the following formulation,
The oil phase (part B) which was heated to 60 ° C. and also heated to 60 ° C. was gradually added to part A with stirring. Then, it cooled to room temperature and obtained the gel composition.
【0018】 A 界面活性物質 3.0重量% グリセリン 4.0 B スクワラン 50.0 流動パラフィン 43.0[0018] A surface-active substance 3.0% by weight Glycerin 4.0 B Squalane 50.0 Liquid paraffin 43.0
【0019】(乳化方法)以下の処方にて、界面活性物
質とグリセリン(A部)を常温にて充分攪拌した後、6
0℃に加温、同じく60℃に加温した油相(B部)をA
部に攪拌しながら徐々に加える。その後70℃に加温し
た水相(C部)を加え撹拌しながら室温まで冷却し乳化
組成物を得た。(Emulsification method) After the surface-active substance and glycerin (part A) were sufficiently stirred at room temperature according to the following formulation, 6
The oil phase (part B) heated to 0 ° C and also to 60 ° C is
Slowly add to the above with stirring. Then, the aqueous phase (part C) heated to 70 ° C. was added, and the mixture was cooled to room temperature with stirring to obtain an emulsified composition.
【0020】 A 界面活性物質 3.0重量% グリセリン 4.0 B スクワラン 20.0 流動パラフィン 20.0 C 1,3−ブチレングリコール 10.0 防腐剤 適量 精製水 残余[0020] A surface-active substance 3.0% by weight Glycerin 4.0 B Squalane 20.0 Liquid paraffin 20.0 C 1,3-butylene glycol 10.0 Preservative Suitable amount Purified water residue
【0021】(ゲル組成物の経時安定性の評価)50℃
にて2週間保存した後の状態を目視にて観察し、以下の
基準に従って経時安定性を評価した。
◎:ゲル化直後と比べ変化がない
○:ゲル化直後と比べ白濁または著しい粘度変化がみら
れる
△:油のしみ出しがみられる
×:ゲルが崩れ明らかな分離がみられる(Evaluation of temporal stability of gel composition) 50 ° C.
The state after storage for 2 weeks was visually observed, and the temporal stability was evaluated according to the following criteria. ◎: No change compared to immediately after gelation ○: White turbidity or remarkable change in viscosity compared to immediately after gelation △: Oil bleeding out ×: Gel collapsed and clear separation is observed
【0022】(乳化組成物の経時安定性の評価)50℃
にて2週間保存した後の状態を目視および光学顕微鏡に
て観察し、以下の基準に従って経時安定性を評価した。
◎:外観、乳化粒子ともに、乳化直後と比べ変化がな
く、乳化粒子は2μm以下である。
○:外観には変化が見られないが乳化粒子は2μm以上
のものがある。
△:分離はみられないが、乳化粒子が大きくなり不均一
である。
×:分離がみられる(Evaluation of stability of emulsion composition over time) 50 ° C.
After 2 weeks of storage, the state was visually observed and observed with an optical microscope, and the temporal stability was evaluated according to the following criteria. ⊚: Both appearance and emulsified particles are the same as immediately after emulsification, and the emulsified particles are 2 μm or less. ◯: No change in appearance is observed, but some emulsified particles are 2 μm or more. Δ: No separation is observed, but the emulsified particles are large and non-uniform. ×: Separation is observed
【0023】(皮膚への刺激性の評価)Haye‘s
Test Chamber(株式会社ヤヨイ製)を用い
て試料を被験者20名の左前腕内側部の皮膚に24時間
閉塞貼付した。判定は試料除去後1及び24時間後に以
下の基準に準じて行った。
皮膚反応の程度 評価点
反応なし 0
軽い紅斑 0.5
紅斑 1.0
紅斑+丘疹又は浮腫 2.0
紅斑+丘疹,浮腫+小水疱 3.0
大水疱 4.0
各被験者を判定後、その評価点の平均を平均評価点と
し、以下の基準に従って皮膚への刺激性を評価した。
◎:0.15未満
○:0.15以上〜0.30未満
△:0.30以上〜0.60未満
×:0.60以上(Evaluation of skin irritation) Haye's
Using Test Chamber (manufactured by Yayoi Co., Ltd.), the sample was affixed to the skin of the inner part of the left forearm of 20 test subjects for 24 hours. The determination was made 1 and 24 hours after the sample was removed according to the following criteria. Degree of skin reaction No evaluation 0 Light erythema 0.5 Erythema 1.0 Erythema + papules or edema 2.0 Erythema + papules, edema + blisters 3.0 Blisters 4.0 After each subject was evaluated, its evaluation The average of the points was used as the average evaluation point, and the skin irritation was evaluated according to the following criteria. ◎: Less than 0.15 ○: 0.15 or more and less than 0.30 △: 0.30 or more and less than 0.60 ×: 0.60 or more
【0024】[0024]
【表1】 [Table 1]
【0025】表1に示すように、界面活性物質として一
般式1に示される化合物のR1がL−ロイシン、R2が
一般式2、R3がナトリウム(以下、サンプル1とす
る)を用いた実施例1のゲル組成物、実施例2の乳化組
成物は経時安定性、皮膚への刺激性は、比較例に示した
天然またはそれ由来の界面活性物質に比べ良好な結果で
あった。As shown in Table 1, as the surface-active substance, R 1 of the compound represented by the general formula 1 is L-leucine, R 2 is the general formula 2, and R 3 is sodium (hereinafter referred to as sample 1). The gel composition of Example 1 and the emulsified composition of Example 2 had good results with respect to stability over time and skin irritation, as compared with the natural or surface-active substances derived from Comparative Examples.
【0026】[0026]
【表2】 [Table 2]
【0027】表2の実施例3〜6に示すようにサンプル
1が0.1〜10重量%の範囲においては特に経時安定
性、皮膚への刺激性は良好な結果であった。As shown in Examples 3 to 6 of Table 2, particularly in the range of 0.1 to 10% by weight of sample 1, stability with time and irritation to skin were good.
【0028】以上説明したように、本発明によれば、一
般式1に示される化合物または/およびその塩を含有す
ることにより、油の乳化能が高く、経時安定性に優れて
おり、更には皮膚に対する刺激が低いく安全性の高いゲ
ル組成物および乳化組成物を提供することが可能とな
る。As described above, according to the present invention, by containing the compound represented by the general formula 1 and / or the salt thereof, the emulsifying ability of oil is high and the stability with time is excellent. It is possible to provide a gel composition and an emulsified composition having low irritation to the skin and high safety.
【0029】[0029]
【実施例】以下に本発明を、詳細に説明するため実施例
を挙げるが、本発明はこれらに限定されるものではな
い。EXAMPLES The present invention will now be described with reference to examples, but the present invention is not limited thereto.
【0030】 実施例7 保湿ゲルクリーム A サンプル1 2.0重量% グリセリン 5.0 B スクワラン 40.0 ミリスチン酸オクチルドデシル 50.0 ステアリルアルコール 2.0 セタノール 1.0 ビタミンEアセテート 適量 香料 適量[0030] Example 7 Moisturizing gel cream A sample 1 2.0% by weight Glycerin 5.0 B Squalane 40.0 Octyldodecyl myristate 50.0 Stearyl alcohol 2.0 Cetanol 1.0 Vitamin E acetate moderate amount Fragrance suitable amount
【0031】A部およびB部を60℃に加温した後、B
部をA部に攪拌しながら徐々に加えてゲル組成物を得
る。その後室温まで冷却する。得られたゲル組成物は経
時安定性に優れており、皮膚に対する刺激が低く、良好
な保湿ゲルクリームであった。After heating the parts A and B to 60 ° C.,
Parts are gradually added to part A with stirring to obtain a gel composition. Then cool to room temperature. The obtained gel composition was excellent in stability over time, had low irritation to the skin, and was a good moisturizing gel cream.
【0032】 実施例8 クレンジングジェル A サンプル2 5.0重量% (一般式1のR1はL−バリン、 R2はC14〜16の飽和分岐のアルキル、R3は水素) ショ糖脂肪酸エステル 1.0 グリセリン 5.0 B 流動パラフィン 50.0 イソノナン酸イソノニル 20.0 ナイロン粉末 1.0 香料 適量 C 1,3−ブチレングリコール 5.0 カルボキシビニルポリマー 1.0 水酸化ナトリウム 0.5 キサンタンガム 0.2 防腐剤 適量 精製水 残余[0032] Example 8 Cleansing Gel A sample 2 5.0 wt% (R 1 of Formula 1 is L- valine, R 2 is alkyl of saturated branched C 14 ~ 16, R 3 is hydrogen) Sucrose fatty acid ester 1.0 Glycerin 5.0 B Liquid paraffin 50.0 Isononyl isononanoate 20.0 Nylon powder 1.0 Fragrance suitable amount C 1,3-butylene glycol 5.0 Carboxyvinyl polymer 1.0 Sodium hydroxide 0.5 Xanthan gum 0 .2 Preservative A suitable amount Purified water Residual
【0033】A部およびB部を60℃に加温した後、B
部をA部に攪拌しながら徐々に加えてゲル組成物を得
る。その後70℃に加温したC部を加え攪拌しながら乳
化し、室温まで冷却する。得られたクレンジングは粒子
径2μm以下の良好な乳化組成物であり、経時安定性、
皮膚への刺激性は良好であった。また、使用感はさっぱ
りし、べたつきの無いものであった。After heating the parts A and B to 60 ° C.,
Parts are gradually added to part A with stirring to obtain a gel composition. After that, part C heated to 70 ° C. is added and the mixture is emulsified with stirring and cooled to room temperature. The resulting cleansing composition is a good emulsion composition having a particle size of 2 μm or less, and has stability over time,
The irritation to the skin was good. Also, the feeling of use was refreshing and there was no stickiness.
【0034】 実施例9 懸濁タイプ化粧水 A サンプル3 1.0重量% (一般式1のR1はL−ロイシン、 R2はC18の分岐アルキル、R3はカリウム) グリセリン 1.0 B ヒマワリ油 5.0 ホホバ油 5.0 ビタミンAパルミテート 0.1 香料 適量 C 防腐剤 適量 pH調整剤 適量 精製水 残余Example 9 Suspension type lotion A Sample 3 1.0% by weight (R 1 of general formula 1 is L-leucine, R 2 is a C 18 branched alkyl, R 3 is potassium) Glycerin 1.0 B Sunflower oil 5.0 Jojoba oil 5.0 Vitamin A palmitate 0.1 Perfume proper amount C preservative proper amount pH adjuster proper amount purified water residual
【0035】A部およびB部を60℃に加温した後、B
部をA部に攪拌しながら徐々に加えてゲル組成物を得
る。その後70℃に加温したC部を加え攪拌しながら乳
化し、室温まで冷却する。得られた懸濁タイプ化粧水は
粒子径2μm以下の良好な乳化組成物であり、経時安定
性、皮膚への刺激性は良好であった。また、使用感はさ
っぱりし、べたつきの無いものであった。After heating the parts A and B to 60 ° C.,
Parts are gradually added to part A with stirring to obtain a gel composition. After that, part C heated to 70 ° C. is added and the mixture is emulsified with stirring and cooled to room temperature. The resulting suspension-type lotion was a good emulsion composition having a particle size of 2 μm or less, and had good stability over time and good skin irritation. Also, the feeling of use was refreshing and there was no stickiness.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/48 A61K 7/48 9/06 9/06 9/107 9/107 47/42 47/42 B01F 17/28 B01F 17/28 17/44 17/44 // C07K 7/00 C07K 7/00 (72)発明者 北原 路郎 愛知県名古屋市西区鳥見町2−7 日本メ ナード化粧品株式会社総合研究所 (72)発明者 中田 悟 愛知県名古屋市西区鳥見町2−7 日本メ ナード化粧品株式会社総合研究所 Fターム(参考) 4C076 AA09 AA17 BB31 CC18 DD01 DD34 DD38 EE41 FF36 FF56 4C083 AA122 AB032 AC022 AC072 AC122 AC352 AD072 AD092 AD222 AD352 AD411 AD412 AD622 AD662 BB01 BB41 BB44 CC04 CC05 CC23 DD23 DD27 DD31 DD41 EE01 EE06 EE10 EE12 FF01 4D077 AA09 AB08 AB11 AB12 AC02 CA11 DC02X DC06X DC10X DC28X DC42X 4H045 AA10 AA30 BA14 BA34 CA11 EA15 EA35 FA73 ─────────────────────────────────────────────────── ─── Continued Front Page (51) Int.Cl. 7 Identification Code FI Theme Coat (Reference) A61K 7/48 A61K 7/48 9/06 9/06 9/107 9/107 47/42 47/42 B01F 17/28 B01F 17/28 17/44 17/44 // C07K 7/00 C07K 7/00 (72) Inventor Jiro Kitahara 2-7 Torimi-cho, Nishi-ku, Aichi Prefecture Japan Menard Cosmetics Research Institute (72) Satoru Nakata Satoru Nakata 2-7 Torimicho, Nishi-ku, Nagoya, Aichi Japan General Cosmetics Co., Ltd. Research Institute F-term (reference) 4C076 AA09 AA17 BB31 CC18 DD01 DD34 DD38 EE41 FF36 FF56 4C083 AA122 AB032 AC022 AC072 AC122 AC352 AD072 AD092 AD222 AD352 AD411 AD412 AD622 AD662 BB01 BB41 BB44 CC04 CC05 CC23 DD23 DD27 DD31 DD41 EE01 EE06 EE10 EE12 FF01 4D077 AA09 AB08 AB11 AB12 AC02 CA11 DC02X DC06X DC10X DC28X DC42X 4H045 AA10 AA30 BA BA34 CA11 EA15 EA35 FA73
Claims (6)
ル、R3は水素)に示される化合物および/またはその
塩を含有することを特徴とするゲル組成物。 【化1】 1. A gel composition comprising a compound represented by the general formula 1 (R 1 is an amino acid, R 2 is alkyl, R 3 is hydrogen) and / or a salt thereof. [Chemical 1]
ロイシン、L−バリンから選ばれるアミノ酸であり、R
2はC8〜C22のアルキルであり、R3は水素または
アルカリ金属であることを特徴とする請求項1に記載の
ゲル組成物。2. R 1 in the general formula 1 is an amino acid selected from L-leucine, L-isoleucine and L-valine, and R 1
The gel composition according to claim 1, wherein 2 is C 8 to C 22 alkyl, and R 3 is hydrogen or an alkali metal.
般式2、R3はナトリウムであることを特徴とする請求
項1乃至請求項2に記載のゲル組成物。 【化2】 3. The gel composition according to claim 1, wherein R 1 in the general formula 1 is L-leucine, R 2 is the general formula 2, and R 3 is sodium. [Chemical 2]
その塩の配合量が0.1〜10重量%であることを特徴
とする請求項1乃至請求項3に記載のゲル組成物。4. The gel composition according to claim 1, wherein the compound of the general formula 1 and / or its salt is contained in an amount of 0.1 to 10% by weight.
組成物に、水を添加して乳化した乳化組成物。5. An emulsified composition obtained by adding water to the gel composition according to claim 1 to emulsify it.
る請求項1乃至請求項5に記載のゲル組成物および/ま
たは乳化組成物。6. The gel composition and / or the emulsified composition according to claim 1, which is used as a skin external preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001384408A JP2003183118A (en) | 2001-12-18 | 2001-12-18 | Gel composition and emulsified composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001384408A JP2003183118A (en) | 2001-12-18 | 2001-12-18 | Gel composition and emulsified composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003183118A true JP2003183118A (en) | 2003-07-03 |
Family
ID=27594143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001384408A Pending JP2003183118A (en) | 2001-12-18 | 2001-12-18 | Gel composition and emulsified composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003183118A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015022944A1 (en) * | 2013-08-12 | 2015-02-19 | 株式会社カネカ | Method for reducing surface free energy and composition having reduced surface free energy |
| WO2017209241A1 (en) * | 2016-06-01 | 2017-12-07 | 株式会社カネカ | Emulsified composition and cosmetic using same |
-
2001
- 2001-12-18 JP JP2001384408A patent/JP2003183118A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015022944A1 (en) * | 2013-08-12 | 2015-02-19 | 株式会社カネカ | Method for reducing surface free energy and composition having reduced surface free energy |
| JPWO2015022944A1 (en) * | 2013-08-12 | 2017-03-02 | 株式会社カネカ | Method for reducing interface free energy and composition with reduced interface free energy |
| WO2017209241A1 (en) * | 2016-06-01 | 2017-12-07 | 株式会社カネカ | Emulsified composition and cosmetic using same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1339413B1 (en) | Compositions comprising complexes of phosphate derivatives of tocopherol | |
| KR20110102336A (en) | Personal hygiene compositions containing volatiles and terpene alcohol | |
| CN1310604A (en) | Compositions containing active ingredients unstable in oxidizing media and their use, in particular their cosmetic use | |
| WO2014100633A1 (en) | Topical compositions comprising ionic fluids | |
| JP5006984B2 (en) | Fatty alcohol compounds, methods for improving the spreadability of products, and uses thereof | |
| JP2003003013A (en) | Oil-in-water emulsifier composition composed of alkylated polysaccharide and cosmetic using the same | |
| JPWO2020066893A1 (en) | Method for Producing Glyceryl Ether-Containing Composition and Glyceryl Ether-Containing Composition | |
| JP3799276B2 (en) | Gel composition and emulsion composition | |
| JP2004075575A (en) | Cornoid lamella resolvent | |
| JP5061984B2 (en) | Adapalene-containing external preparation composition | |
| JP5306675B2 (en) | Sucrose fatty acid ester and emulsifier for oil-in-water emulsion composition | |
| JP7002461B2 (en) | Gel-like composition | |
| JP2003183118A (en) | Gel composition and emulsified composition | |
| JP5109383B2 (en) | Adapalene-containing external preparation composition | |
| JP3712673B2 (en) | Gel composition and oil-in-water (O / W) type composition | |
| JP2000344697A (en) | Long-chain branched alcohol, cosmetic and external preparation using the same | |
| JP4834236B2 (en) | Silicone derivatives and oils, cosmetics and external preparations containing the same | |
| JP3453462B2 (en) | Cosmetics | |
| JP2673887B2 (en) | Cosmetics | |
| JP2006306793A (en) | Emulsified cosmetic | |
| JP5856761B2 (en) | External preparation for skin and method for producing the same | |
| JP5670008B2 (en) | Adapalene-containing external preparation composition | |
| JP4806601B2 (en) | Liquid bath agent | |
| JP5109382B2 (en) | Adapalene-containing external preparation composition | |
| JP2000191499A (en) | Moisturizing skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050428 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050517 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050714 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050823 |